---
title: Comparison Between Handheld Rebound Tonometer and Applanation Tonometer in IOP Measurement in Paediatric Glaucomas
nct_id: NCT06766799
overall_status: NOT_YET_RECRUITING
sponsor: Sohag University
study_type: OBSERVATIONAL
primary_condition: Glaucoma
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT06766799.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT06766799"
ct_last_update_post_date: 2025-01-09
last_seen_at: "2026-05-12T06:36:53.813Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# Comparison Between Handheld Rebound Tonometer and Applanation Tonometer in IOP Measurement in Paediatric Glaucomas

**NCT ID:** [NCT06766799](https://clinicaltrials.gov/study/NCT06766799)

## Key Facts

- **Status:** NOT_YET_RECRUITING
- **Study Type:** OBSERVATIONAL
- **Target Enrollment:** 160
- **Lead Sponsor:** Sohag University
- **Conditions:** Glaucoma
- **Start Date:** 2025-03-01
- **Completion Date:** 2025-12-01
- **CT.gov Last Update:** 2025-01-09

## Brief Summary

To compare the accuracy between handheld rebound tonometer \& applanation tonometer in IOP measurement in pediatric glaucoma cases

## Eligibility

- **Minimum age:** 3 Years
- **Maximum age:** 18 Years
- **Sex:** ALL
- **Healthy Volunteers:** Yes

```
Inclusion Criteria:

* Patients attending to our pediatric glaucoma clinic diagnosed with glaucoma aged \>18 years old are subjected to IOP Measurements.

Exclusion Criteria:

* \*\*Patients aged more than 18 years old

  * patients with scarred cornea
```

## Arms

- **Group A ( Glaucomatous Patients)**
- **Group B ( Control Group)**

## Interventions

- **Rebound and Applanation Tonometer** (DEVICE) — Measurement of Intraocular Pressure

## Primary Outcomes

- **Comparison between the IOP Measurments by Rebound Tonometer & Applanation tonometer** _(time frame: over nine months)_ — To compare the accuracy between handheld rebound tonometer \& applanation tonometer in IOP measurement in pediatric glaucoma cases

## Recent Field Changes (last 30 days)

- `armsInterventions.arms` — added _(2026-05-12)_
- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.maxAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `armsInterventions.interventions` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT06766799.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT06766799*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*